Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Raw Materials (2025)

Abeona Therapeutics has reported Raw Materials over the past 1 years, most recently at $5.5 million for Q4 2025.

  • Quarterly results put Raw Materials at $5.5 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $5.5 million (changed N/A YoY), and the annual figure for FY2025 was $5.5 million, changed.
  • Raw Materials for Q4 2025 was $5.5 million at Abeona Therapeutics.
  • Over the last five years, Raw Materials for ABEO hit a ceiling of $5.5 million in Q4 2025 and a floor of $5.5 million in Q4 2025.